CTNM
Contineum Therapeutics, Inc.
12.70$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | 100.0% | – | – | |
| – | – | 0.4% | – | – | |
| – | – | 100.0% | – | – | |
| – | – | 55.2% | – | – | |
| – | – | 12.6% | – | – | |
| – | – | 132.2% | – | – | |
| – | – | -32.2% | – | – | |
| – | – | 0.4% | – | – | |
| – | – | 46.3% | – | – | |
| – | – | 0.9% | – | – | |
| – | – | 45.4% | – | – | |
| – | – | 47.1% | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.